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i.org/1in vivo to date. We discovered that by exciting ﬂuorescence at 345 nm and emitting at 420
nm, 3-amino-4-hydroxy-5-nitrobenzene sulfonic acid monohydrate (3-ANA) elicits a brown
ﬂuorescence that is characteristic of just TG. Therefore, localization of TG in coronary
plaques and normal segments that were obtained from 19 human autopsy cases was
examined by color ﬂuorescent angioscopy (CFA) and microscopy using 3-ANA as a
biomarker of TG. By CFA, the percentage (%) incidence of TG in 23 normal segments, 13
white plaques without lipid deposition, 18 white plaques (growth stage) with lipid deposi-
tion, 11 yellow plaques without necrotic core (mature stage), and 12 yellow plaques with
necrotic core (advanced mature stage) was 95, 92, 50, 27, and 25, respectively. By color
ﬂuorescent microscopy, TG deposited mostly in the ﬁbrotic area of the plaques. Contrary to
the general belief that TG amount increases with plaque maturation, the results indicated
that TG was deposited in most of the normal coronary segments, but the amount decreased
with plaque maturation. If 3-ANA becomes applicable clinically, the CFA system could be
used for imaging TG within coronary plaques in patients in vivo.  2016 The Authors.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). (Am J Cardiol 2016;118:1306e1310)During our search for a biomarker for TG, we discovered
that it exhibited a brown ﬂuorescence in the presence of
3-amino-4-hydroxy-5-nitrobenzene sulfonic acid mono-
hydrate (3-ANA)1 by excitation at 340 nm and emission at
420 nm. The present study using color ﬂuorescent angio-
scopy (CFA) and color ﬂuorescent microscopy (CFM)
aimed to clarify whether the brown ﬂuorescence excited by
3-ANA is speciﬁc for TG and, thus, show TG deposited in
human coronary plaques in anticipation of clinical
application.
Methods
TG singularly does not exhibit autoﬂuorescence but
when mixed with 3-ANA, brown ﬂuorescence is evoked.
Therefore, 3-ANA was used as an indicator of TG in this
study. To clarify whether the ﬂuorescent color of TG evoked
by 3-ANA is characteristic, the color ﬂuorescence of the
major substances that constitute atherosclerotic plaques2
was examined by CFM. Chemically pure substances were
used for this purpose. A CFM system with a band pass ﬁlter
of 340  15 nm and a band absorption ﬁlter of 420 nm wasation for Cardiovascular Research, Funabashi, Japan;
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0.1016/j.amjcard.2016.07.065used for ﬂuorescent imaging. The details of CFM are
described elsewhere.3,4
CFA system is consisted of a ﬂuorescence-excitation
unit, an angioscope (VecMover; Clinical Supply Co, Gifu,
Japan), a ﬂuorescence-emission unit, and a camera. The
system enables observation of a coronary segment up to
7 cm in length by a single saline ﬂush and has been
approved for clinical use by the Japanese Ministry of Health
and Labor, supported by National Insurance, on a
commercial basis in Japan.5 The details of this CFA system
are described elsewhere.5,6 The intensity of the ﬂuorescence
images was arbitrarily deﬁned as strong, weak, and
absent when the exposure time required for imaging was
1, 1< and 5, and 5s<, respectively.6
The limitation of sensitivity of the CFA system was
examined using the major substances comprising athero-
sclerotic plaques6 as the target. It was revealed that their
ﬂuorescence was not detectable by the CFA system when
their concentration was 106 M.6
The conventional angioscopy system is consisted of a
4.5-F angioscope, light source, and a 3-coupled chilled
device digital camera (Olympus). The details of the
procedure are described elsewhere.5,7 Plaque by conven-
tional angioscopy was deﬁned as a nonmotile and
protruding or lining mass clearly demarcated from the
adjacent normal wall and whose shape, location, and color
did not alter after saline solution ﬂush. Plaques were further
classiﬁed as white or yellow based on their surface color. A
normal segment was deﬁned as a milky white and smooth-
surfaced portion of the vessel without any protrusion.8
Surface color of the plaques was measured by an
AquaCosmos image analyzer (C7746; Hamamatsu
Photonics, Hamamatsu, Japan).7ccess article
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Figure 1. Color ﬂuorescent angioscopic images of TG in a white plaque in a patient with chronic renal disease who died of acute pneumonia. (A) White plaque
by conventional angioscopy (arrow). (B) Blue ﬂuorescence of the plaque was imaged by CFA before, indicating the rich collagen ﬁbers. (B-1) Brown
ﬂuorescence elicited by application of 3-ANA to the same plaque (arrow). (C) Luminal surface scan by CFM showed brown ﬂuorescence indicating the
presence of TG (arrow). Transected surface of the same plaque showed deposition of TG in the inner portions of the plaque where lipid deposition was not
observed (arrow in D). Deposition of TG was not observed in the outer layer where lipids deposited (arrowheads in D and E). (L, I, and M): Lumen, intima,
and media, respectively. Scale bars ¼ 100 mm.
Coronary Artery Disease/TG in Human Coronary Plaques 1307This in vitro study was carried out with the approval of
the Ethical Committees of Japan Foundation for Cardio-
vascular Research, Funabashi-Futawa Hospital and Toho
University. After obtaining the written informed consent of
the families concerned, 29 coronary arteries (17 left anterior
descending arteries, 5 left circumﬂex arteries, and 7 right
coronary arteries) were excised from 19 successive autopsy
cases from April 1, 2008, to November 1, 2014 (age 61 
3 years, 7 women and 12 men): death from acute myocardial
infarction (4), aortic dissection (2), diabetic nephropathy (5),
cerebral infarction (2), pancreatic carcinoma (1), hepato-
cellular carcinoma (3), and gastric cancer (2). The remaining
28 arteries were difﬁcult to excise or used for other purpose.
Coronary arteries were obtained from autopsy cases
within 5 to 12 hours after death, and the following exami-
nations were performed within 2 to 5 hours thereafter. A
Y-connector was introduced into the proximal portion of the
coronary artery being examined for perfusion with saline
solution at a rate of 10 ml/min. Then, the angioscope, as
described earlier, was introduced through the connector for
observation of the artery. Initially, conventional angioscopy
was carried out to detect plaque and because the light irra-
diated from the angioscope tip was visible through thecoronary wall, the angioscope tip and, accordingly, the
targeted plaque could be conﬁrmed.
After observation by conventional angioscopy, the light
guide and the image guide were connected to the ﬂuores-
cence excitation and emission units, respectively. A band
pass ﬁlter of 340  15 nm and a band absorption ﬁlter of
420 nm were set, and a control image was obtained under
perfusion of saline solution. After ceasing the perfusion,
0.5 ml of 2% 3-ANA solution was injected into the perfu-
sion circuit, and 5 minutes later, saline solution perfusion
was restarted and the target plaque was imaged again.
A total of 54 plaques were conﬁrmed by conventional
angioscopy and CFA in 29 arteries. The 4- to 5-mm-long
portion of vessel in which the observed plaque was located
was isolated by transecting its proximal and the distal ends
at the shorter axes to avoid any damage to the plaque.
Subsequently, the isolated segment was cut longitudinally to
open the lumen. The 23 normal segments were similarly
isolated. The 52 of the 54 isolated coronary segments that
contained plaques and 22 of the 23 normal segments were
mounted on a deck glass in such a way that the luminal
surface of the plaque faced the deck glass. The surface was
then scanned by CFM at 10 or 40 magniﬁcation using
Figure 2. Differences in the deposition sites of TG. (AeA-2) Normal coronary segment before the addition of 3-ANA shows a blue ﬂuorescence, indicating the
rich presence of collagen I. After the addition of 3-ANA, a brown ﬂuorescence was elicited not only in the intima but also in the media, indicating the presence
of TG. (BeB-2)White plaque showing TG deposited in the inner layers of the plaque (arrow in B-1) but not in the lipid-deposited portions stained red with Oil
Red O (arrowheads in B-1 and B-2). (CeC-2) Yellow plaque with NC showing TG co-deposited with calcium in a spotty pattern in the NC. Arrow in C-1: TG.
Arrowheads in C-1 and C-2: calcium.
1308 The American Journal of Cardiology (www.ajconline.org)light wavelength ﬁlters in similar to those used for CFA.
The remaining 2 plaques and 1 normal segment were not
used because they were damaged during preparation.
In the 49 plaques and 22 normal segments used for
observation of the luminal surface by CFM scanning, the
center of the plaque was transected and half was again
immersed in 3-ANA solution for 5 minutes because the
3-ANA injected into the perfusion circuit might not have
penetrate into the entire wall. Next, it was mounted on a
deck glass in such a way that the transected surface faces thedeck glass, and the transected surface was scanned by CFM
to examine localization of TG. Three plaques were
destroyed because of calcium deposition and were not
used for scanning. Furthermore, the relations between the
deposition site of TG and plaque color determined by
conventional angioscopy and the presence or absence of a
necrotic core (NC) were examined.
After CFM scanning, the raw sample, which was cut into
slices of 30 to 40 mm thickness at the shorter axis, had lipids
stained red, calcium as black, collagen ﬁbers and smooth
Table 1
Percentage (%) incidence of triglyceride (TG) deposition in normal
segments and plaques of human coronary artery examined by color
ﬂuorescent angioscopy (CFA) and microscopy (CFM)
Plaque
morphology
Normal
segments
White plaques Yellow plaques
Lipid(-) Lipid (þ) NC(-) NC(þ)
(A) Color ﬂuorescent angioscopy
n 23 13 16 11 12
TG present 22(95%) 12(92%) 9(56%) 3(27%) 3(25%)*
(B)Color ﬂuorescent microscopy
(a)Luminal surface scan
n 22 13 17 11 11
TG present 20 (91%) 10(77%) 8(47%) 3(27%) 2(18%)†
(C) Transected surface scan
n 22 12 16 10 11
TG present 22(100%) 11(97%) 10(62%) 5(50%) 4(36%)
Normal segments and plaques were classiﬁed by conventional angio-
scopy and histology. The incidence of TG deposition was highest in normal
segments, showed a tendency to decrease in white plaques and further in
yellow plaques. The incidence in yellow plaques NC (þ) was signiﬁcantly
lower than normal segments. No signiﬁcant difference in incidence was
observed between CFA and CFM.
Lipid () ¼ lipid absent; Lipid (þ) ¼ lipid present; n ¼ number of
preparations examined; NC () ¼ necrotic core absent; NC (þ) ¼ necrotic
core present.
* p <0.05 versus normal segments observed by color ﬂuorescent
angioscopy.
† p <0.05 versus normal segments observed by color ﬂuorescent
microscopic scanning of the luminal surface.
Table 2
Deposition sites of triglycerides (TG) examined by transected surface scan
of normal segments and plaques by color ﬂuorescent microscopy (CFM)
Plaque
morphology
Normal
segments
White plaques Yellow plaques
Lipid(-) Lipid(þ) NC(-) NC(þ)
n 22 12 16 10 11
Deposition sites
(A) Fibrotic
area
22*†z (37%) 12x (100%) 6{k (100%) 2 (20%) 0
(B) Lipid area 0 0 2 (12%) 1 (10%) 1 (9%)
(C) Both areas 0 0 (12%) 2 (20%) 2 (9%) 1
(D) Within NC 0 0 0 0 2 (18%)
Lipid () ¼ lipid absent; Lipid (þ) ¼ lipid present; n ¼ total number of
preparations examined; NC () ¼ necrotic core absent; NC (þ) ¼ necrotic
core present. Both areas ¼ ﬁbrotic and lipid areas.
TG deposited in ﬁbrotic area in normal segments and white plaques Lipid
(-) and not only in ﬁbrotic area but also in lipid area in yellow plaques.
* p <0.05 versus yellow plaques NC ().
† p <0.01 versus yellow plaques NC (þ).
z p <0.0001 versus lipid area, both area, or within NC.
x p <0.01 versus lipid area, both area, or within NC.
{ p <0.01 versus yellow plaques NC (þ).
k p <0.05 versus within NC.
Coronary Artery Disease/TG in Human Coronary Plaques 1309muscles as blue with Oil Red O, and methylene blue dyes
for histologic study.
The data obtained were tested by the Fisher’s exact test.
A value of p <0.05 was considered to be statistically
signiﬁcant.
Results
TG did not autoﬂuoresce, but it presented a brown
ﬂuorescence in the presence of 3-ANA. This ﬂuorescent
color was not exhibited by any of the other major known
substances that comprise atherosclerotic plaques,2,4
indicating that this ﬂuorescent color was characteristic of
just TG.
Figure 1 shows a white plaque by conventional angio-
scopy. It exhibited blue autoﬂuorescence, indicating the
presence of abundant collagen I.3 After the administration of
3-ANA, the plaque exhibited diffuse brown ﬂuorescence,
indicating diffuse deposition of TG. Diffuse brown
ﬂuorescence was also observed by luminal surface scanning
of the same plaque. On transected surface scanning of the
same plaque, brown ﬂuorescence occupied the inner layer
(luminal side) of the plaque but not the outer layer (medial
side) of the plaque where lipids deposited according to
histologic examination.
In the angioscopically normal coronary segments, TG
was diffusely deposited in the ﬁbrotic intima in the majority
of specimens examined, irrespective of underlying disease
or cause of death (Figure 2, Tables 1 and 2), and also
frequently in the media (Figure 2). In white plaques without
lipid deposition, TG was deposited in the ﬁbrotic intima(Tables 1 and 2), whereas in white plaques with lipid
deposition in outer layer (medial side), TG was deposited
mostly in the ﬁbrotic area but infrequently in the lipid
deposition area (Figures 1 and 2, Table 2). In yellow plaques
with or without NC, TG deposition was less frequently
observed by CFA and CFM (Tables 1 and 2). In a small
number of yellow plaques with NC, TG deposits were
observed within the NC (Figure 2, Table 2). As a
consequence, the incidence of TG deposition studied by
CFA was greatest in the normal segments and showed a
tendency to decrease in the order of white plaques without
lipid deposition, white plaques with lipid deposition, and
yellow plaques without NC. The incidence of TG in yellow
plaques with NC that was examined by CFA and CFM
luminal surface scan was signiﬁcantly smaller than that of
normal segments (Table 1).
Discussion
Lattermann et al9 visualized TG in excised rabbit aortic
plaques by Raman spectroscopy but not in human coronary
plaques. In the present study, a lowemolecular weight dye
(3-ANA)1 was found to evoke a brown ﬂuorescence by TG
only. Thus, visualization of TG in a given plaque was
achieved, enabling analysis of the differences in deposition
patterns of TG in human coronary plaques ex vivo. The
mechanisms by which 3-ANA evoked ﬂuorescence by TG
are not known. One possibility is that 3-ANA became
conjugated to TG to form an adduct that provoked the
brown ﬂuorescent color. Because there were no other major
substances that exhibited a brown ﬂuorescent color, it is
believed that it is characteristic of TG and that 3-ANA can
be used as a biomarker of TG.
The percentage (%) incidence of TG studied by CFA and
CFM was highest in the normal coronary intima in which
collagen ﬁbers are abundant and showed to decrease in the
1310 The American Journal of Cardiology (www.ajconline.org)order of white plaques and yellow plaques. In addition, TG
was deposited mostly in the ﬁbrotic area (collagen ﬁber and/
or elastic ﬁber area) but infrequently in the lipid deposition
area. That ﬁnding suggested that TG deposition decreased
with loss of ﬁbrous tissues or with an increase in lipid
deposition. It is conceivable that TG was catabolized or
replaced by the lipids or was incorporated in the lipoproteins
or apolipoproteins. The results in our study are contrary to
the general belief that TG content increases with plaque
maturation.10 It is well known that lipoproteins, such as
oxidized low-density lipoprotein, low-density lipoprotein, or
apolipoprotein B, contain TG.11,12 These lipoproteins and
apolipoproteins increased with plaque maturation in our
previous studies in human coronary plaques ex vivo.2,3 In
reported studies, human plaques (mostly carotid plaques
excised by endoatherectomy) were homogenized and TG
content was measured by biochemical techniques, such as
chromatography.11 We suppose that lipoproteins and
apolipoproteins were broken down by homogenization to
detach TG; thus, both the detached and pre-existing free TG
were measured, showing an apparent increase in TG content
in the plaques.
Detection rate by transected surface scan by CFM showed
a tendency to be greater than that of CFA. Probably, TG
deposited in deeper area was visualized by CFM but not by
CFA. Because no signiﬁcant differences were noted between
CFA and CFM in detecting TG within the coronary plaques,
the present CFA system has a potential use for imaging TG in
the human coronary wall in vivo. If 3-ANA becomes appli-
cable in clinical situation, the relation between plaque TG and
ischemic coronary events could be clariﬁed more deﬁnitively
by the present CFA system in patients in vivo.
The present experimental study entailing the use of
3-ANA as a biomarker of TG appears to be the ﬁrst to image
native TG in the human vascular wall. However, this study
has some shortcomings: (1) imaging was limited to the
target within 200 mm from the plaque surface, and therefore,
deposits in the deeper layers cannot be analyzed by this
CFA system.3 However, by improving the light source, light
guide, image guide, and camera, the TG deposited deeper
than 200 mm would be visualized. (2) Clinical safety of
3-ANA remains to be clariﬁed before application in patients.(3) The number of patients belonging to each disease group
was very small, and therefore, it is not conclusive whether
TG deposition in coronary plaques is related to underlying
disease.Disclosures
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